Welcome to our dedicated page for Fitlife Brands SEC filings (Ticker: FTLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FitLife Brands files SEC reports that document results and Regulation FD communications for its nutritional supplement and wellness products business. Recent 8-Ks include earnings releases, call transcripts, corporate presentation materials, and financial results discussions that separate online and wholesale sales activity and incorporate Irwin Naturals after the completed asset acquisition.
Other filings record material definitive agreements, including the credit agreement used in connection with the Irwin Naturals asset purchase and debt refinancing, along with stockholder-meeting results covering director elections, executive-compensation advisory votes, vote-frequency determinations, and auditor ratification.
FitLife Brands, Inc. appointed Ryan Hansen as President, effective May 18, 2026. Hansen, 38, had been Executive Vice President since November 2023 and previously held leadership roles at Pearl Street Dental Partners, Bain & Company, and Worthington Industries.
In connection with his promotion, Hansen received options to acquire 75,000 shares of common stock at an exercise price of $10.50 per share, vesting over three years, and 50,000 performance stock units that vest only if the 30‑day volume weighted average price reaches $20.00 within five years. His base salary increased from $275,000 to $300,000. He is an at‑will employee with no formal employment agreement, and the company reports no related‑party transactions or family relationships involving Hansen.
FitLife Brands President Ryan P. Hansen received new equity awards. He was granted 50,000 performance stock units, plus 46,500 incentive stock options and 28,500 non-qualified stock options, each for common stock. The options have a $10.50 exercise price, time-based vesting over three years, and expire on May 15, 2031.
The 50,000 performance stock units vest only if the 30-day volume weighted average price of FitLife’s common stock reaches at least $20.00 before the fifth anniversary of the grant, aligning part of his compensation with longer-term share price performance.
FitLife Brands reported strong top-line growth but softer profitability for the first quarter ended March 31, 2026. Revenue rose to $25.3 million, up 59% from $15.9 million a year earlier, driven mainly by the Irwin acquisition, which contributed $10.3 million of wholesale revenue.
Legacy FitLife revenue declined 22%, with wholesale down 28% and online down 18%, reflecting weaker sales to key retailers and lower online demand. Consolidated gross margin fell to 37.6% from 43.1% as Irwin carries structurally lower margins, and contribution margin decreased to 32.7% from 36.5%.
Net income declined to $1.7 million from $2.0 million, and diluted EPS fell to $0.17 from $0.20. Adjusted EBITDA was $3.3 million, down 3% year over year. The company ended the quarter with $37.6 million outstanding on its term loan, $4.2 million on its revolver, and cash of $1.2 million, for net debt of about $40.6 million, modestly lower than at year-end 2025.
FitLife Brands reported strong top-line growth for the quarter ended March 31, 2026, with revenue rising to $25.3 million, up 59% from $15.9 million a year earlier, largely driven by the acquisition of Irwin Naturals. Legacy FitLife revenue declined 22% to $12.5 million as both online and wholesale sales softened, particularly at MRC and GNC.
Gross profit increased to $9.5 million, but gross margin fell to 37.6% from 43.1% as Irwin operates at lower margins. Net income decreased 15% to $1.7 million, or $0.18 basic EPS, reflecting higher SG&A and interest expense from the expanded business and debt structure. Adjusted EBITDA was essentially flat at $3.3 million.
The company ended the quarter with $104.3 million in total assets, including $51.2 million of intangibles and $19.4 million of goodwill, and total liabilities of $58.9 million. FitLife carried $37.6 million on its Irwin term loan and $4.2 million on its revolving credit line, while maintaining positive working capital of $10.8 million and generating $2.5 million of operating cash flow.
FitLife Brands, Inc. filed Amendment No. 1 to its annual report for the year ended December 31, 2025 to update Part III disclosures on directors, executive compensation, ownership, related parties and auditor matters.
The filing details a largely independent board and three standing committees, outlines at‑will arrangements and option grants for senior executives, and reports that CEO Dayton Judd beneficially owns 5,831,058 shares, or 58.7% of the common stock as of April 21, 2026. It also shows non‑affiliate equity market value of $50.75 million, continued use of Weinberg & Company as auditor, and higher 2025 audit fees versus 2024.
FITLIFE BRANDS, INC. director Seth Yakatan reported an open-market purchase of common stock. He bought 164 shares at a weighted average price of $15.3601 per share, increasing his direct holdings to 593 shares of FITLIFE BRANDS common stock.
The purchase was executed under a pre-arranged Rule 10b5-1 trading plan, and occurred through multiple trades within a price range of $15.29 to $15.75 per share.
FITLIFE BRANDS, INC. director Matthew Lingenbrink made an open-market purchase of the company’s common stock. On April 10, 2026, he bought 3,000 shares at $9.76 per share, increasing his direct holdings to 8,800 shares. According to a footnote, the purchase followed Board approval to temporarily extend the trading window under the company’s Insider Trading Policy after disclosure of the expected range of operating results for the quarter ending March 31, 2026 and confirmation that there was no undisclosed material information.
FITLIFE BRANDS, INC. director Grant Robert Dawson made an open-market purchase of 3,000 shares of Common Stock at $9.98 per share, increasing his direct holdings to 158,000 shares. The shares were bought after the Board approved a temporary extension of the trading window under the company’s Insider Trading Policy, following disclosure of the expected range of operating results for the quarter ending March 31, 2026 and confirmation that there was no undisclosed material information.
FitLife Brands discussed fourth-quarter and full-year 2025 results, emphasizing the first full quarter of owning Irwin Naturals. Q4 2025 revenue was $25.9 million, up 73% year over year, driven mainly by Irwin, while Legacy FitLife brands saw revenue declines amid softer consumer demand.
Wholesale Q4 revenue reached $15.5 million (up 213%), online revenue was $10.5 million (up 4%), and adjusted gross margin was 37.0% versus 41.4% a year ago due to Irwin’s lower historical margins. Net income was $1.6 million versus $2.1 million, while adjusted EBITDA rose 14% to $3.5 million. Management highlighted Irwin’s Q4 revenue of $12.6 million and fast-growing Amazon channel, now at roughly $0.8 million in monthly revenue. The company reduced term debt by $1.9 million to $44.7 million and outlined initiatives to improve Irwin’s supply chain, extend product shelf life, grow off-Amazon awareness, cross-sell brands through Irwin’s sales team, and trim SG&A, while noting ongoing macro and Amazon-related headwinds and choosing not to give 2026 guidance.
FitLife Brands reported strong 2025 revenue growth but weaker profitability. Full-year revenue rose to $81.5M from $64.5M, helped by the Irwin acquisition, while net income fell to $6.3M from $9.0M as margins and expenses pressured earnings.
Gross margin declined to 38.6% from 43.6%, and adjusted EBITDA was roughly flat at $14.0M. In Q4 2025, revenue grew 73% to $25.9M, but gross margin slipped to 34.5%. The company ended 2025 with a term loan of $39.1M, revolver borrowings of $5.6M, and cash of $1.6M, and is prioritizing debt reduction.
Management highlighted persistent demand weakness across most brands in early 2026, but noted rapid online growth for Irwin, particularly on Amazon, where annualized revenue has reached an estimated $9–10M run rate.